Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy

Journal of Investigative Dermatology

Volumn 130, Issue 9, 2010, Pages 2250-2258

  Hiscutt, Emma L ^a   Hill, David S ^a   Martin, Shaun ^a   Kerr, Ryan ^a   Harbottle, Andrew ^a   Birch Machin, Mark ^a   Redfern, Christopher P F ^b   Fulda, Simone ^c   Armstrong, Jane L ^a   Lovat, Penny E ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BORTEZOMIB; CASPASE; FENRETINIDE; RAF PROTEIN; RAS PROTEIN; SHORT HAIRPIN RNA; X LINKED INHIBITOR OF APOPTOSIS;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER STAGING; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

EID: 77955712441     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.146     Document Type: Article

References (31)

1. Armstrong JL, Veal GJ, Redfern CP et al. (2007) Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours. Apoptosis 12:613-622
2. Balch CM, Soong SJ, Gershenwald JE et al. (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-3634
3. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553
4. Burstein E, Ganesh L, Dick RD et al. (2004) A novel role for XIAP in copper homeostasis through regulation of MURR1. EMBO J 23:244-254
5. Chawla-Sarkar M, Bae SI, Reu FJ et al. (2004) Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ 11:915-923
6. Corazzari M, Lovat PE, Armstrong JL et al. (2007) Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57. Br J Cancer 96:1062-1071
7. Davies H, Bignell GR, Cox C et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-954
8. de Snoo FA, Hayward NK (2005) Cutaneous melanoma susceptibility and progression genes. Cancer Lett 230:153-186
9. Dean E, Jodrell D, Connolly K et al. (2009) Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer. J Clin Oncol 27:1660-1666
10. Dong J, Phelps RG, Qiao R et al. (2003) BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res 63:3883-3885
11. Emanuel PO, Phelps RG, Mudgil A et al. (2008) Immunohistochemical detection of XIAP in melanoma. J Cutan Pathol 35:292-297
12. Fecher LA, Cummings SD, Keefe MJ et al. (2007) Toward a molecular classification of melanoma. J Clin Oncol 25:1606-1620
13. Garnett MJ, Marais R (2004) Guilty as charged: B-RAF is a human oncogene. Cancer Cell 6:313-319
14. Gorden A, Osman I, Gai W et al. (2003) Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Cancer Res 63:3955-3957
15. Gray-Schopfer VC, Karasarides M, Hayward R et al. (2007) Tumor necrosis factor-alpha blocks apoptosis in melanoma cells when BRAF signaling is inhibited. Cancer Res 67:122-129
16. Hill DS, Martin S, Armstrong JL et al. (2009) Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma. Clin Cancer Res 15:1192-1198
17. Kluger HM, McCarthy MM, Alvero AB et al. (2007) The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by phenoxodiol is associated with carboplatin sensitiza-tion. J Transl Med 5:6
18. LaCasse EC, Cherton-Horvat GG, Hewitt KE et al. (2006) Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis. Clin Cancer Res 12:5231-5241
19. Lovat PE, Corazzari M, Armstrong JL et al. (2008) Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res 68:5363-5369
20. Lovat PE, Ranalli M, Annichiarrico-Petruzzelli M et al. (2000) Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma. Exp Cell Res 260:50-60
21. Notarbartolo M, Poma P, Perri D et al. (2005) Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett 224: 53-65
22. Omholt K, Karsberg S, Platz A et al. (2002) Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression. Clin Cancer Res 8:3468-3474
23. Poulaki V, Mitsiades CS, Kotoula V et al. (2007) The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro. Invest Ophthalmol Vis Sci 48:4706-4719
24. Schimmer AD, Dalili S, Batey RA et al. (2006) Targeting XIAP for the treatment of malignancy. Cell Death Differ 13:179-188
25. Schimmer AD, Estey EH, Borthakur G et al. (2009) Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleo-tide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia. J Clin Oncol 27: 4741-4746
26. Thompson JF, Scolyer RA, Kefford RF (2005) Cutaneous melanoma. Lancet 365:687-701
27. Todd C, Reynolds NJ (1998) Up-regulation of p21WAF1 by phorbol ester and calcium in human keratinocytes through a protein kinase C-dependent pathway. Am J Pathol 153:39-45
28. Ueda Y, Richmond A (2006) NF-kappaB activation in melanoma. Pigment Cell Res 19:112-124
29. Vogler M, Walczak H, Stadel D et al. (2009) Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma. Cancer Res 69:2425-2434
30. Vucic D, Fairbrother WJ (2007) The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clin Cancer Res 13:5995-6000
31. Zobel K, Wang L, Varfolomeev E et al. (2006) Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs. ACS Chem Biol 1:525-533